In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers
- 31 July 2004
- journal article
- Published by Elsevier in Human Immunology
- Vol. 65 (7) , 692-699
- https://doi.org/10.1016/j.humimm.2004.04.001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Metabolic Biotinylation of Secreted and Cell Surface Proteins from Mammalian CellsBiochemical and Biophysical Research Communications, 2001
- A minimal peptide substrate in biotin holoenzyme synthetase‐catalyzed biotinylationProtein Science, 1999
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules.The Journal of Experimental Medicine, 1996
- A versatile plasmid expression vector for the production of biotinylated proteins by site-specific, enzymatic modification in Escherichia coliGene, 1996
- Production of soluble MHC class II proteins with covalently bound single peptidesNature, 1994
- Use of Peptide Libraries to Map the Substrate Specificity of a Peptide-Modifying Enzyme: A 13 Residue Consensus Peptide Specifies Biotinylation in Escherichia coliNature Biotechnology, 1993
- The birA gene of Escherichia coli encodes a biotin holoenzyme synthetaseJournal of Molecular Biology, 1981
- The influence of polyvalency on the binding properties of antibodiesImmunochemistry, 1972
- Antibody affinity—III the role of multivalenceImmunochemistry, 1972